Maximal acute GVHD grade within 45 days of first infusion
| . | Maximum acute GVHD grade . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 . | I . | II . | III . | IV . | ||||||
| Virus . | n . | % . | n . | % . | n . | % . | n . | % . | n . | % . |
| CMV (n = 23) | 19 | (82.6) | 3 | (13.0) | 1 | (4.4) | 0 | (0.0) | 0 | (0.0) |
| EBV (n = 9) | 8 | (88.9) | 1 | (11.1) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
| AdV (n = 18) | 15 | (83.3) | 2 | (11.1) | 0 | (0.0) | 1 | (5.6) | 0 | (0.0) |
| Total (n = 50) | 42 | (84.0) | 6 | (12.0) | 1 | (2.0) | 1 | (2.0) | 0 | (0.0) |
| . | Maximum acute GVHD grade . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 . | I . | II . | III . | IV . | ||||||
| Virus . | n . | % . | n . | % . | n . | % . | n . | % . | n . | % . |
| CMV (n = 23) | 19 | (82.6) | 3 | (13.0) | 1 | (4.4) | 0 | (0.0) | 0 | (0.0) |
| EBV (n = 9) | 8 | (88.9) | 1 | (11.1) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
| AdV (n = 18) | 15 | (83.3) | 2 | (11.1) | 0 | (0.0) | 1 | (5.6) | 0 | (0.0) |
| Total (n = 50) | 42 | (84.0) | 6 | (12.0) | 1 | (2.0) | 1 | (2.0) | 0 | (0.0) |